Kerridge BT, Pickering RP, Saha TD, Ruan WJ, Chou SP, Zhang H, Jung J, Hasin DS (2017) Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States. Drug Alcohol Depend 170:82–92. https://doi.org/10.1016/j.drugalcdep.2016.10.038
Papazisis G, Tzachanis D (2014) Pregabalin’s abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther 52(8):709–716. https://doi.org/10.5414/CP202118
Article
CAS
PubMed
Google Scholar
Drug Enforcement Administration (2005) Department of Justice schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Fed Regist 70(144):43633
Google Scholar
Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C (2020) Pregabalin abuse in combination with other drugs: monitoring among methadone patients. Front Psychiatry 10:1022
Article
Google Scholar
Bastiaens L, Galus J, Mazur C (2016) Abuse of gabapentin is associated with opioid addiction. Psychiatr Q 87(4):763–767
Article
Google Scholar
Gabr AA (2019) Prevalence and risk factors of pregabalin misuse among patients with substance use disorder. Al-Azhar Assiut Med J 17(4):393
Article
Google Scholar
King MA (2018) Pregabalin and gabapentin associated with depression and suicidal ideation. BMJ 363:k4979
Article
Google Scholar
Dean A, Sullivan KM, Soe MM (2013) OpenEpi: Open Source Epidemiologic Statistics for Public Health. Version 2.3.1
First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition. SCID-I/P, New York, pp 94–91
Google Scholar
El Missiry A, Sorour A, Sadek A, Fahy TA, Mawgoud M, Asaad T (2003) Homicide and psychiatric illness: an Egyptian study [MD thesis]. Faculty of Medicine, Ain Shams University, Cairo
Google Scholar
First M, Gibbon M, Spitzer R (1997) Structured Clinical Interview for DSM-IV axis II personality disorders (SCID-II). American Psychiatric Press; Inc
Zimmerman M, Pfohl B, Coryell W, Stangl D, Corenthal C (1988) Diagnosing personality disorder in depressed patients: a comparison of patient and informant interviews. Arch Gen Psychiatry 45:733–737
Article
CAS
Google Scholar
Hatata H, Khalil A, Asaad T (2003) Dual diagnosis in substance use disorders a study in Egyptian sample. Unpublished MD thesis. Institute of psychiatry .Ain shams university, Egypt
Google Scholar
Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100
Article
Google Scholar
Beck, A. T., & Beamesderfer, A. (1974). Assessment of depression: the depression inventory. S. Karger.
Google Scholar
Abdel-Khalek AM (1998) Internal consistency of an Arabic adaptation of the Beck Depression Inventory in four Arab countries. Psychol Rep 82(1):264–266
Article
CAS
Google Scholar
Beck AT, Steer RA, Ranieri WF (1988) Scale for suicide ideation: psychometric properties. J Clin Psychol 44:499–505
Article
CAS
Google Scholar
Hamilton M (1959) Hamilton Anxiety Rating Scale. Brit J Med Psychol 32:50–55
Article
CAS
Google Scholar
Maier W, Buller R, Philipp M, Heuser I (1988) The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 14(1):61–68
Article
CAS
Google Scholar
Thompson E (2015) Hamilton rating scale for anxiety (HAM-A). Occup Med 65(7):601
Article
Google Scholar
Fateem L (1998) Arabic manual of Hamilton anxiety scale translated and adapted by Lotfy Fateem. The Anglo-Egyptian Bookshop, Egypt
Google Scholar
IBM (2020) IBM SPSS Statistics for Windows, Version 27. IBM Corp, Armon http://www-01.ibm.com/support/docview.wss?uid=swg27049428
Google Scholar
Lai HMX, Cleary M, Sitharthan T, Hunt GE (2015) Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 154:1–13
Article
Google Scholar
Terracciano A, Löckenhoff CE, Crum RM, Bienvenu OJ, Costa PT (2008) Five-factor model personality profiles of drug users. BMC Psychiatry 8(1):1–10
Article
Google Scholar
Tandon VR, Mahajan V, Gillani ZH, Mahajan A (2013) Pregabalin-induced self-harm behavior. Indian J Pharmacol 45(6):638
Article
Google Scholar
Kienast T, Stoffers J, Bermpohl F, Lieb K (2014) Borderline personality disorder and comorbid addiction: epidemiology and treatment. Deutsches Ärzteblatt Int 111(16):280
Google Scholar
Evren C, Kural S, Erkiran M (2006) Antisocial personality disorder in Turkish substance dependent patients and its relationship with anxiety, depression and a history of childhood abuse. Israel J Psychiatry Relat Sci 43(1):40
Google Scholar
Parmar A, Kaloiya G (2018) Comorbidity of personality disorder among substance use disorder patients: a narrative review. Indian J Psychol Med 40(6):517–527
Article
Google Scholar
Sayed SM, Ahmad HEK, Sayied NE, El-Aziz A, Mohamed A (2020) Effect of psycho-educational program on depression among drug addict patients at Assiut University Hospital. Assiut Sci Nurs J 8(20):45–55
Google Scholar
Mohamed II, Ahmad HEK, Hassaan SH, Hassan SM (2020) Assessment of anxiety and depression among substance use disorder patients: a case-control study. Middle East Curr Psychiatry 27:1–8
Article
Google Scholar
Singh D, Yadav JS, Jamuda BK, Singh P (2019) Oral pregabalin as premedication on anxiolysis and stress response to laryngoscopy and endotracheal intubation in patients undergoing laparoscopic cholecystectomy: a randomized double-blind study. Anesth Essays Res 13(1):97
Article
Google Scholar
Fahmy MT, Haggag WL, Mohamed KA, Baalash AA (2015) A study of the personality traits and the level of anxiety in suicidal polydrug users. Egyptian J Psychiatry 36(2):106
Article
Google Scholar
Rodríguez-Cintas L, Daigre C, Braquehais MD, Palma-Alvarez RF, Grau-López L, Ros-Cucurull E et al (2018) Factors associated with lifetime suicidal ideation and suicide attempts in outpatients with substance use disorders. Psychiatry Res 262:440–445
Article
Google Scholar
Philips B, Wennberg P, Konradsson P, Franck J (2018) Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: a randomized controlled feasibility study. Eur Addict Res 24(1):1–8
Article
Google Scholar